Pharmacology Imipenem/cilastatin
1 pharmacology
1.1 mechanism of action
1.2 bioavailability
1.3 distribution
1.4 protein binding
1.5 metabolism
1.6 elimination
pharmacology
mechanism of action
imipenem inhibits bacterial cell-wall synthesis binding penicillin-binding proteins; cilastatin prevents renal metabolism of imipenem.
bioavailability
intramuscular injection:
imipenem: 60–75%
cilastatin: 95–100%
distribution
the drug distributed rapidly , tissues , fluids, including sputum, pleural fluid, peritoneal fluid, interstitial fluid, bile, aqueous humor, reproductive organs, , bone; highest concentrations occur in pleural fluid, interstitial fluid, peritoneal fluid, , reproductive organs; low concentrations occur in csf; crosses placenta, , enters breast milk
protein binding
imipenem: 13–21%
cilastatin, 40%
metabolism
imipenem metabolized in kidney dehydropeptidase 1; activity blocked cilastatin.
elimination
half-life (both drugs): 60 min; prolonged renal impairment. excretion (both drugs): urine (~70% unchanged drug)
Comments
Post a Comment